Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction.
Gibson CM, Buros J, Ciaglo LN, Southard MC, Takao S, Harrigan C, Filopei J, Lew M, Marble SJ, Murphy SA, Cohen MG; TITAN-TIMI 34 Investigators. Gibson CM, et al. Among authors: ciaglo ln. Am J Cardiol. 2007 Jul 1;100(1):13-7. doi: 10.1016/j.amjcard.2007.01.068. Epub 2007 May 11. Am J Cardiol. 2007. PMID: 17599433 Clinical Trial.
Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days.
Pride YB, Buros JL, Lord E, Southard MC, Harrigan CJ, Ciaglo LN, Sabatine MS, Cannon CP, Gibson CM; TIMI Study Group. Pride YB, et al. Among authors: ciaglo ln. J Thromb Thrombolysis. 2008 Oct;26(2):106-12. doi: 10.1007/s11239-007-0075-z. Epub 2007 Jul 12. J Thromb Thrombolysis. 2008. PMID: 17624497
Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
Gibson CM, Murphy SA, Pride YB, Kirtane AJ, Aroesty JM, Stein EB, Ciaglo LN, Southard MC, Sabatine MS, Cannon CP, Braunwald E; TIMI Study Group. Gibson CM, et al. Among authors: ciaglo ln. Am Heart J. 2008 Jan;155(1):133-9. doi: 10.1016/j.ahj.2007.08.034. Epub 2007 Nov 19. Am Heart J. 2008. PMID: 18082504 Clinical Trial.
Timing and duration of myocardial ischemia on Holter monitoring following percutaneous coronary intervention and their association with clinical outcomes (a PROTECT-TIMI 30 Substudy Analysis).
Gibson CM, Pride YB, Buros JL, Ciaglo LN, Morrow DA, Scirica BM, Stone PH; TIMI Study Group. Gibson CM, et al. Among authors: ciaglo ln. Am J Cardiol. 2009 Jul 1;104(1):36-40. doi: 10.1016/j.amjcard.2009.02.044. Epub 2009 May 4. Am J Cardiol. 2009. PMID: 19576318 Clinical Trial.
Usefulness of clopidogrel in abolishing the increased risk of reinfarction associated with higher platelet counts in patients with ST-elevation myocardial infarction (results from CLARITY-TIMI 28).
Gibson CM, Ly HQ, Murphy SA, Ciaglo LN, Southard MC, Stein EB, Buros JL, Sabatine MS, Cannon CP; TIMI Study Group. Gibson CM, et al. Among authors: ciaglo ln. Am J Cardiol. 2006 Sep 15;98(6):761-3. doi: 10.1016/j.amjcard.2006.03.062. Epub 2006 Aug 2. Am J Cardiol. 2006. PMID: 16950180
Transfusion associated microchimerism: a heretofore little-recognized complication following transfusion.
Kunadian V, Zorkun C, Gibson WJ, Nethala N, Harrigan C, Palmer AM, Ogando KJ, Biller LH, Lord EE, Williams SP, Lew ME, Ciaglo LN, Buros JL, Marble SJ, Gibson CM. Kunadian V, et al. Among authors: ciaglo ln. J Thromb Thrombolysis. 2009 Jan;27(1):57-67. doi: 10.1007/s11239-008-0268-0. Epub 2008 Sep 3. J Thromb Thrombolysis. 2009. PMID: 18766299 Review.
13 results